626PPROGNOSTIC IMPACT OF HER2, EGFR, AND C-MET STATUS ON OVERALL SURVIVAL OF ADVANCED GASTRIC CANCER PATIENTS TREATED WITH STANDARD CHEMOTHERAPY WITHOUT TRASTUZUMAB IN A FIRST-LINE TREATMENT: A JAPANESE MULTICENTER COLLABORATIVE RETROSPECTIVE STUDY
Shinozaki, E., Fuse, N., Kuboki, Y., Kuwata, T., Nishina, T., Kadowaki, S., Machida, N., Yuki, S., Ooki, A., Kajiura, S., Kimura, T., Yamanaka, T., Sasaki, T., Shitara, K., Nagatsuma, A., Yoshino, T.,Volume:
25
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdu334.11
Date:
September, 2014
File:
PDF, 64 KB
2014